Chemotherapy for operable gastric cancer: Results of the Dutch randomised FAMTX trial

European Journal of Cancer

Volumn 35, Issue 4, 1999, Pages 558-562

  Songun, I ^a   Keizer, H J ^a   Hermans, J ^a   Klementschitsch, P ^b   De Vries, J E ^c   Wils, J A ^d   Van der Bijl, J ^e   Van Krieken, J H J M ^a   Van de Velde, C J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HOSPITAL DE WEEZENLANDEN   (Netherlands)

^c Sophia Hospital   (Netherlands)

^d LAURENTIUS HOSPITAL   (Netherlands)

^e Gregorius Hospital   (Netherlands)

Author keywords

Chemotherapy; FAMTX; Gastric cancer; Prognosis; Resectability; Surgery

Indexed keywords

DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GASTRECTOMY; GASTROINTESTINAL TOXICITY; HAIR LOSS; HEMATOLOGIC DISEASE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LUNG TOXICITY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; NETHERLANDS; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PREOPERATIVE CARE; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0033119140     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00429-8     Document Type: Article

References (29)

1. Akoh J.A., Sedgwick D.M., Macintyre I.M. Improving results in the treatment of gastric cancer: an 11 year audit. Br. J. Surg. 78:1991;349-351.
2. Breaux J.R., Bringaze W.L., Chappuis C.W., et al. Adenocarcinoma of the stomach: a review of 35 years and 1710 cases. World J. Surg. 14:1990;580-586.
3. Cady B., Rossi R.L., Silverman M.L., et al. Gastric adenocarcinoma. A disease in transition. Arch. Surg. 124:1989;303-308.
4. Bonenkamp J.J., Songun I., Hermans J., et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 345:1995;745-748.
5. Cuschieri A., Fayers P., Fielding J., et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet. 347:1996;995-999.
6. Hermans J., Bonenkamp J.J., Boon M.C., et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J. Clin. Oncol. 11:1993;1441-1447.
7. Hermans J., Bonenkamp J.J. In reply. J. Clin. Oncol. 12:1994;879-880.
8. Ajani J.A., Ota D.M., Jessup M., et al. Resectable gastric carcinoma: an evaluation of preoperative and postoperative chemotherapy. Cancer. 68:1991;1501-1506.
9. Wilke H., Preusser P., Fink U., et al. Pre-operative chemotherapy in locally advanced and non-resectable gastric cancer. A phase II study with etoposide, doxorubicin and cisplatin. J. Clin. Oncol. 7:1989;1318-1326.
10. Kelsen D., Karpeh M., Schwartz G., et al. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J. Clin. Oncol. 14:(6):1996;1818-1828.
11. Kiyabu M., Leichman L., Chandrasoma P. Effects of preoperative chemotherapy on gastric adenocarcinomas: a morphologic study of 25 cases. Cancer. 70:1992;2239-2245.
12. Leichman L., Silberman H., Leichman C.G., et al. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. J. Clin. Oncol. 10:1993;1933-1942.
13. Klein H.O. Long-term results with FAMTX in advanced gastric cancer. Anticancer Res. 9:1989;1025-1026.
14. Wils J.A., Klein H.O., Wagener D.J.Th., et al. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - a step ahead in the treatment of advanced gastric cancer: a trial of the EORTC Group. J. Clin. Oncol. 5:1991;827-831.
15. Findlay M., Cunningham D., Norman A., et al. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann. Oncol. 5:1994;609-616.
16. Kang YK, Choi DW, Im YH. A phase III randomized comparison of neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer. Proc Am Soc Clin Oncol 1997, 154 (abstr. 66).
17. Roelofs E.J.M., Wagener D.J.Th., Conroy Th., et al. Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer. Ann. Oncol. 4:1993;426-428.
18. Kelsen D., Atiq O.T., Saltz L., et al. FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment trial in gastric cancer. J. Clin. Oncol. 10:1992;541-548.
19. Preusser P., Wilke H., Achterrath W., et al. Phase II study with the combination etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer. J. Clin. Oncol. 7:1989;1310-1317.
20. Muggia F. How to improve survival after diagnosis of gastric cancer? It's back to the drawing board. J. Clin. Oncol. 11:1993;1437-1438.
21. Sparano J.A., Schwartz E.L., Salva K.M., et al. Phase II trial of etoposide, doxorubicin (adriamycin) and cisplatin (EAP regimen) in advanced gastric cancer. Am. J. Clin. Oncol. 13:1990;374-378.
22. Leichman L., Berry B. Cisplatin therapy for adenocarcinoma of the stomach. Semin. Oncol. 18:(Suppl. 3):1991;25-33.
23. Sue-Ling H.M., Johnston D., Martin I.G., et al. Gastric cancer: a curable disease in Britain. Br. Med. J. 307:1993;591-596.
24. Hallissey M.T., Allum W.H., Jewkes A.J., et al. Early detection of gastric cancer. Br. Med. J. 301:1990;513-515.
25. Rougier Ph., Mahjoubi M., Lasser Ph., et al. Neoadjuvant chemotherapy in locally advanced gastric carcinoma - a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum. Eur. J. Cancer. 30:1994;1269-1275.
26. Nakajima T., Ota K., Ishihara S., et al. Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann. Surg. Oncol. 4:(3):1997;203-208.
27. Facchini G., Tortoriello A., Caponigro F., et al. Neoadjuvant chemotherapy in locally advanced gastric cancer: preliminary results of a phase III trial with a modified FAMTX combination. Oncol. Reports. 2:1995;727-730.
28. Yonemura Y., Sawa T., Kinoshita K., et al. Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J. Surg. 17:1993;256-262.
29. Webb A., Cunningham D., Scarffe J.H., et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J. Clin. Oncol. 15:(1):1997;261-267.